Prime Therapeutics (Prime) manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. Prime is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans, and Ingrid is ...
We forecast that it will generate $9.91 billion in worldwide sales for Amazon, up 43% from last year’s event. What are the top drivers of Prime membership? Fast and free shipping remains the top reason for subscribing to Prime, but Prime Video has become an important benefit that attracts...
We test the efficacy of novel therapeutics for cognitive and psychiatric disorders. We also test drugs for abuse potential and abuse prevention. We specialize in cognitive testing (Learning, Memory, and Attention) Tests on rodent and Non-Human Primates are overseen by a full-time academic who ru...
As the promise of harnessing the immune system to fight cancer grabs headlines around the industry , venture stalwarts Fidelity Biosciences and Atlas Venture have teamed up to launch Unum Therapeutics , a Cambridge , MA , startup with a hybrid approach to the field . 1 Learn more by requesti...
, Editas Medicine, Excelsior Genomics, Pairwise Plants, Poseida Therapeutics, SeQure Dx, Transposagen Biopharmaceuticals and Verve Therapeutics (formerly known as Endcadia). K.P. has a financial interests in SeQure Dx, Inc.. L.P. has financial interests in Edilytics, SeQure Dx, Inc. and ...
is a co-founder, funding recipient and scientific advisor of EvolveImmune Therapeutics; the company has no relation to this study. Additional information Peer review information Peer reviewer reports are available. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in...
abivax, lexeo therapeutics and more sa news mon, oct. 02, 2023 ipo roundup: webuy global, maison solutions and more sa news mon, sep. 25, 2023 ipo roundup: adlai nortye, jyong biotech and more sa news mon, aug. 21, 2023 singapore-based primech files for proposed $23m us ipo sa ...
SW Casscells,E Granger,J Swedorske,... - 《American Journal of Therapeutics》 被引量: 35发表: 2008年 The Effect of Statin Therapy on the Incidence of Infections: A Retrospective Cohort Analysis Methods This was a retrospective cohort study of patients enrolled as Tricare Prime or Plus in th...
Seamlessly scale up your synthesis of siRNA and ASO for RNA therapeutics from early-stage development to commercial manufacturing with a comprehensive portfolio of Thermo Scientific TheraPure 2’ modified RNA phosphoramidites and TheraPure customization capabilities. Modification...
D.R.L. is a consultant and equity holder of Prime Medicine, Beam Therapeutics, Pairwise Plants and Chroma Medicine, companies that use genome editing or genome engineering. Peer review Peer review information Nature Protocols thanks Sangsu Bae, Hyongbum H. Kim, Myungjae Song, Goosang Yu and...